rs1555454566

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM4PP3PP5_Very_Strong

The NM_014249.4(NR2E3):​c.194_202delACGGCTGCA​(p.Asn65_Cys67del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000899 in 1,445,784 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. N65N) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000090 ( 0 hom. )

Consequence

NR2E3
NM_014249.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 9.66

Publications

4 publications found
Variant links:
Genes affected
NR2E3 (HGNC:7974): (nuclear receptor subfamily 2 group E member 3) This protein is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as well as in maintenance of proper cell function in adults. Members of this family are characterized by discrete domains that function in DNA and ligand binding. This gene encodes a retinal nuclear receptor that is a ligand-dependent transcription factor. Defects in this gene are a cause of enhanced S cone syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
NR2E3 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 37
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • enhanced S-cone syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Goldmann-Favre syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 12 uncertain in NM_014249.4
PM4
Nonframeshift variant in NON repetitive region in NM_014249.4.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
Variant 15-71811552-CCTGCAACGG-C is Pathogenic according to our data. Variant chr15-71811552-CCTGCAACGG-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 551852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR2E3NM_014249.4 linkc.194_202delACGGCTGCA p.Asn65_Cys67del disruptive_inframe_deletion Exon 2 of 8 ENST00000617575.5 NP_055064.1 Q9Y5X4-1
NR2E3NM_016346.4 linkc.194_202delACGGCTGCA p.Asn65_Cys67del disruptive_inframe_deletion Exon 2 of 7 NP_057430.1 Q9Y5X4-2F1D8Q9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR2E3ENST00000617575.5 linkc.194_202delACGGCTGCA p.Asn65_Cys67del disruptive_inframe_deletion Exon 2 of 8 1 NM_014249.4 ENSP00000482504.1 Q9Y5X4-1
NR2E3ENST00000621098.1 linkc.194_202delACGGCTGCA p.Asn65_Cys67del disruptive_inframe_deletion Exon 2 of 7 1 ENSP00000479962.1 Q9Y5X4-2
NR2E3ENST00000621736.4 linkc.-71_-63delACGGCTGCA 5_prime_UTR_variant Exon 4 of 10 2 ENSP00000479254.1 Q8IVZ9

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000135
AC:
3
AN:
222772
AF XY:
0.00000830
show subpopulations
Gnomad AFR exome
AF:
0.0000776
Gnomad AMR exome
AF:
0.0000318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000100
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000899
AC:
13
AN:
1445784
Hom.:
0
AF XY:
0.00000976
AC XY:
7
AN XY:
717570
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000301
AC:
1
AN:
33182
American (AMR)
AF:
0.0000713
AC:
3
AN:
42060
Ashkenazi Jewish (ASJ)
AF:
0.000232
AC:
6
AN:
25852
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38930
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5698
European-Non Finnish (NFE)
AF:
0.00000272
AC:
3
AN:
1104766
Other (OTH)
AF:
0.00
AC:
0
AN:
59818
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000003), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.394
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Enhanced S-cone syndrome Pathogenic:3
Mar 20, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 17, 2020
Natera, Inc.
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 19, 2024
3billion
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: Inframe deletion located in a nonrepeat region: predicted to change the length of the protein and disrupt normal protein function. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000551852 /PMID: 10655056). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

Enhanced S-cone syndrome;C1970163:Retinitis pigmentosa 37 Pathogenic:2
Sep 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2017
Counsyl
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not provided Pathogenic:1
May 29, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551852). This variant has been observed in individual(s) with autosomal recessive enhanced S-cone syndrome/Goldmann-Favre syndrome (PMID: 12963616, 19273793, 19898638, 21364904, 28541266). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.008%). This variant, c.194_202del, results in the deletion of 3 amino acid(s) of the NR2E3 protein (p.Asn65_Cys67del), but otherwise preserves the integrity of the reading frame. -

Retinal dystrophy Pathogenic:1
Aug 13, 2019
Blueprint Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Pathogenic:1
Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
9.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555454566; hg19: chr15-72103892; API